Publication: 232

Publication: 232

Dose-escalation of filgrastim does not improve efficacy: Clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Cancer Treat Rev vol 34 (3) 223-230

Year:: 2008
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Long-Term-Followup
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:
Grants:: U10 CA047577, U10 CA032291, CA33601, U10 CA035279, U10 CA031946, U10 CA033601, U10 CA031946-27, U10 CA047642, CA31946, U10 CA003927

Corr. Author:
Authors:: Minetta C. Liu George D. Demetri Donald A. Berry Larry Norton Gloria Broadwater Nicholas J. Robert David Duggan Daniel F. Hayes I.Craig Henderson Alan Lyss Judith Hopkins Peter A. Kaufman P. Kelly Marcom Jerry Younger Nancy Lin Katherine Tkaczuk Eric P. Winer Clifford A. Hudis

Networks:

Study: Alliance-9141
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:

Keywords:: Article